Logo image of AVTX.AS

AVANTIUM (AVTX.AS) Stock Fundamental Analysis

AMS:AVTX - Euronext Amsterdam - NL0012047823 - Common Stock - Currency: EUR

0.847  +0.08 (+10.57%)

Fundamental Rating

2

AVTX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 27 industry peers in the Professional Services industry. AVTX may be in some trouble as it scores bad on both profitability and health. AVTX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

AVTX had negative earnings in the past year.
AVTX had a negative operating cash flow in the past year.
In the past 5 years AVTX always reported negative net income.
AVTX had a negative operating cash flow in each of the past 5 years.
AVTX.AS Yearly Net Income VS EBIT VS OCF VS FCFAVTX.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

With a Return On Assets value of -9.31%, AVTX is not doing good in the industry: 82.14% of the companies in the same industry are doing better.
With a Return On Equity value of -28.03%, AVTX is not doing good in the industry: 82.14% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -9.31%
ROE -28.03%
ROIC N/A
ROA(3y)-13.42%
ROA(5y)-20.86%
ROE(3y)-43.37%
ROE(5y)-45.66%
ROIC(3y)N/A
ROIC(5y)N/A
AVTX.AS Yearly ROA, ROE, ROICAVTX.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

AVTX has a Gross Margin of 81.08%. This is in the better half of the industry: AVTX outperforms 75.00% of its industry peers.
AVTX's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for AVTX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 81.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.37%
GM growth 5Y-1.4%
AVTX.AS Yearly Profit, Operating, Gross MarginsAVTX.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

More info and screens

1

2. Health

2.1 Basic Checks

AVTX does not have a ROIC to compare to the WACC, probably because it is not profitable.
AVTX has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, AVTX has more shares outstanding
Compared to 1 year ago, AVTX has a worse debt to assets ratio.
AVTX.AS Yearly Shares OutstandingAVTX.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AVTX.AS Yearly Total Debt VS Total AssetsAVTX.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

AVTX has an Altman-Z score of -1.91. This is a bad value and indicates that AVTX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -1.91, AVTX is not doing good in the industry: 89.29% of the companies in the same industry are doing better.
AVTX has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
AVTX has a better Debt to Equity ratio (0.30) than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z -1.91
ROIC/WACCN/A
WACC7.16%
AVTX.AS Yearly LT Debt VS Equity VS FCFAVTX.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M 150M

2.3 Liquidity

AVTX has a Current Ratio of 0.25. This is a bad value and indicates that AVTX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.25, AVTX is not doing good in the industry: 89.29% of the companies in the same industry are doing better.
AVTX has a Quick Ratio of 0.25. This is a bad value and indicates that AVTX is not financially healthy enough and could expect problems in meeting its short term obligations.
AVTX has a worse Quick ratio (0.24) than 89.29% of its industry peers.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.24
AVTX.AS Yearly Current Assets VS Current LiabilitesAVTX.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 35.80% over the past year.
AVTX shows a small growth in Revenue. In the last year, the Revenue has grown by 6.78%.
The Revenue has been growing by 8.76% on average over the past years. This is quite good.
EPS 1Y (TTM)35.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.26%
Revenue 1Y (TTM)6.78%
Revenue growth 3Y24.44%
Revenue growth 5Y8.76%
Sales Q2Q%-2.9%

3.2 Future

The Earnings Per Share is expected to grow by 22.32% on average over the next years. This is a very strong growth
AVTX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 54.51% yearly.
EPS Next Y12.74%
EPS Next 2Y18.96%
EPS Next 3Y22.32%
EPS Next 5YN/A
Revenue Next Year73.52%
Revenue Next 2Y74.46%
Revenue Next 3Y56.42%
Revenue Next 5Y54.51%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AVTX.AS Yearly Revenue VS EstimatesAVTX.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M 150M 200M 250M
AVTX.AS Yearly EPS VS EstimatesAVTX.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AVTX. In the last year negative earnings were reported.
Also next year AVTX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AVTX.AS Price Earnings VS Forward Price EarningsAVTX.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AVTX.AS Per share dataAVTX.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

AVTX's earnings are expected to grow with 22.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.96%
EPS Next 3Y22.32%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AVTX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AVANTIUM

AMS:AVTX (5/2/2025, 7:00:00 PM)

0.847

+0.08 (+10.57%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)03-19 2025-03-19/amc
Earnings (Next)08-13 2025-08-13
Inst Owners9.37%
Inst Owner ChangeN/A
Ins Owners5.03%
Ins Owner ChangeN/A
Market Cap73.66M
Analysts78.33
Price Target4.3 (407.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.99%
PT rev (3m)-3.99%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.87%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-9.83%
Revenue NY rev (3m)-9.83%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.5
P/FCF N/A
P/OCF N/A
P/B 0.77
P/tB 0.8
EV/EBITDA N/A
EPS(TTM)-0.36
EYN/A
EPS(NY)-0.47
Fwd EYN/A
FCF(TTM)-1.09
FCFYN/A
OCF(TTM)-0.41
OCFYN/A
SpS0.24
BVpS1.1
TBVpS1.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.31%
ROE -28.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 81.08%
FCFM N/A
ROA(3y)-13.42%
ROA(5y)-20.86%
ROE(3y)-43.37%
ROE(5y)-45.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.37%
GM growth 5Y-1.4%
F-Score2
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1126.95%
Cap/Sales 278.74%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.24
Altman-Z -1.91
F-Score2
WACC7.16%
ROIC/WACCN/A
Cap/Depr(3y)919.16%
Cap/Depr(5y)570.66%
Cap/Sales(3y)308.29%
Cap/Sales(5y)199.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.26%
EPS Next Y12.74%
EPS Next 2Y18.96%
EPS Next 3Y22.32%
EPS Next 5YN/A
Revenue 1Y (TTM)6.78%
Revenue growth 3Y24.44%
Revenue growth 5Y8.76%
Sales Q2Q%-2.9%
Revenue Next Year73.52%
Revenue Next 2Y74.46%
Revenue Next 3Y56.42%
Revenue Next 5Y54.51%
EBIT growth 1Y-10.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year25.06%
EBIT Next 3Y27.17%
EBIT Next 5Y31.62%
FCF growth 1Y11.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-112.37%
OCF growth 3YN/A
OCF growth 5YN/A